Loading
Latest filing published 08 Dec 2020 for BIOSPECIFICS TECHNOLOGIES CORP, €538.4M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Our data holds just one disclosure by Endo International plc, dated 8 December 2020, reporting an open-market purchase worth €538.4M in Biospecifics Technologies Corp. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration